Research feed
Recently added diabetes research, organized by intervention and outcome.
Sorted by when Dediabetes added each study.
Mobile phone-based app with or without telehealth counseling in adults with type 2 diabetes.
This study compared the effects of empagliflozin and glimepiride on endothelial function in individuals with type 2 diabetes, finding no significant differences in flow-mediated dilation but notable differences in body weight and fluid volume.
EWP supplementation improved nutritional status and reduced oxidative stress in diabetic hemodialysis patients.
The Finerenone Trial investigated the efficacy and safety of finerenone compared to placebo in patients with heart failure, demonstrating significant benefits.
The FIGARO-DKD trial subgroup analysis evaluated finerenone in patients with type 2 diabetes and chronic kidney disease, finding significant reductions in kidney failure risk.
This study evaluated the effects of higher doses of semaglutide on glucose levels in type 2 diabetes patients, finding modest additional benefits at higher doses.
The Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial demonstrated that Icosapent ethyl significantly reduced cardiovascular events compared to placebo.
This study evaluated a concentrated transdiagnostic treatment for patients with Type 2 diabetes and sleep disorders, showing significant improvements in sleep-related outcomes over 12 months.
This study examined pregnancy and post-delivery outcomes in women with type 1 diabetes using non-automated insulin pumps versus multiple daily injections. It found higher rates of preterm delivery and caesarean sections associated with insulin pumps.
This study analyzed the effects of Multifactorial Therapy (MT) versus Usual Care (UC) in participants with type 2 diabetes, finding significant reductions in major adverse cardiovascular events and all-cause mortality.
Latest Evidence
Build your workspace to keep track of the latest diabetes research.
